Europe — EMA
Itonorm (Itopride Hydrochloride)
GNH USA supplies Itonorm (Itopride Hydrochloride), a gastroprokinetic for functional dyspepsia, gastric motility disorders and GERD.
Request sourcing
What is Itopride Hydrochloride?
Itopride Hydrochloride, the active ingredient in Itonorm, is a gastroprokinetic presented as a tablet for oral use. It treats functional dyspepsia, gastric motility disorders and gastro‑oesophageal reflux disease in adult patients.
GNH USA supplies Itonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Itopride Hydrochloride used for?
Itonorm (itopride hydrochloride) is used in disorders of gastrointestinal motility and functional dyspepsia.
Functional dyspepsia: improves post‑prandial fullness and early satiety. Gastric motility disorders: enhances gastric emptying and reduces gastric stasis. Gastro‑oesophageal reflux disease: reduces reflux episodes and associated heartburn.
What are the side effects of Itopride Hydrochloride?
Itonorm may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Nausea - Diarrhea - Abdominal pain - Headache
Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., tremor, rigidity) - Elevated liver enzymes - Severe allergic reactions such as anaphylaxis
What precautions apply to Itopride Hydrochloride?
Before prescribing Itonorm, clinicians should consider several safety aspects.
Assess renal function: adjust use in patients with severe renal impairment. Monitor hepatic function: watch for elevated liver enzymes during therapy. Use cautiously in patients with known sensitivity to dopamine antagonists. Avoid in individuals with documented hypersensitivity to itopride. Store at room temperature: keep in the original pack, protect from moisture and heat.
What does Itopride Hydrochloride interact with?
Itonorm can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.
Major Interactions (Avoid): - Potent CYP3A4 inhibitors: may increase itopride plasma concentrations. - Anticholinergic agents: may counteract the pro‑kinetic effect of itopride.
Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may increase the risk of nausea. - Anticoagulants: monitor for potential gastrointestinal bleeding. - Diuretics: observe electrolyte balance, especially potassium.



